" /> Autologous Anti-MUC16 CAR-mbIL15-Safety Switch T-cells PRGN-3005 - CISMeF





Preferred Label : Autologous Anti-MUC16 CAR-mbIL15-Safety Switch T-cells PRGN-3005;

NCIt synonyms : PRGN-3005 UltraCAR-T Cells; Autologous PRGN-3005 UltraCAR-T Cells; Autologous CAR-T Cells PRGN 3005; Autologous Anti-MUC16 CAR-T Cells PRGN-3005;

NCIt definition : A preparation of autologous T-lymphocytes that have been genetically modified to co-express three transgenes using the Sleeping Beauty (SB) transposon system and include a chimeric antigen receptor (CAR) targeting the unshed portion of the tumor-associated antigen (TAA) human mucin 16 (MUC16, cancer antigen 125; CA125; FLJ14303), a membrane-bound IL-15 (mbIL15) and a safety/kill switch, with potential immunostimulating and antineoplastic activities. Upon introduction of the autologous anti-MUC16 CAR-mbIL15-safety switch T-cells PRGN-3005 into the patient, the T-cells target and bind to MUC16-expressing tumor cells, thereby inducing selective toxicity in MUC16-expressing tumor cells. MUC16, a member of the mucin family of glycoproteins, is overexpressed on a variety of cancer cell types. IL-15 is a pro-survival cytokine that is required for the maintenance of long-lived CD8 memory T-cells and use of mbIL15 preserves T stem-cell memory (TSCM) through sustained IL-15 signaling, improves T-cell persistence and potentiates the immune response against tumor cells. The safety switch can promote selective elimination of the CAR-T cells. The SB system permits integration of the CAR, the IL-15 fusion variant and safety switch transgenes into T-cells without the need for viral vectors and accelerates the manufacturing process.;

Molecule name : PRGN-3005; PRGN 3005;

NCI Metathesaurus CUI : CL937966;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
11/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.